Given the functional attributes of AMPK in lipid and carbohydrate metabolism, AMPK is considered as an important therapeutic target for treating metabolic diseases including obesity and type 2 diabetes [43]. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.